Combined procedure for severe mitral regurgitation and atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests whether combining a valve repair procedure with a heart rhythm reset procedure is safe and effective for people with severe mitral regurgitation and atrial fibrillation. It may help improve heart function and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have already had a successful mitral valve repair (TEER) with only mild or less leakage after the procedure.
- You do not have a blood clot in the heart, your heart's left upper chamber is smaller than 5.5 cm, and you are suitable for a procedure to reset your heart rhythm (electrical cardioversion).
- You are able to understand the study and give your consent to participate.
- You have not had a stroke or a mini-stroke in the last 30 days.
- You are not taking medications that prevent blood clots or irregular heartbeats if you have conditions that make these medicines unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure that combines two treatments: fixing a leaky heart valve (mitral regurgitation) and treating an irregular heartbeat (atrial fibrillation) at the same time. It aims to improve symptoms and heart function in people with both conditions.
This study tests whether a procedure called catheter ablation, which uses heat or cold to fix irregular heartbeats, is safe and effective for people who have atrial fibrillation and have recently had a mitral valve repair. If you qualify, it might help restore a normal heart rhythm and improve your symptoms.
This study tests whether a catheter ablation procedure (a way to fix abnormal heart rhythms) can help people who have both constant atrial fibrillation and severe mitral regurgitation (a leaky heart valve). It is for people whose heart valve leak is caused by the rhythm problem, not by valve damage.
This trial tests a minimally invasive procedure to repair a leaky mitral valve in people with a specific type of heart failure. The goal is to see if the procedure, called transcatheter edge-to-edge repair (TEER), is safe and effective in reducing symptoms and improving heart function.
This study tests a new combination treatment approach for people with long-standing persistent atrial fibrillation (a type of irregular heartbeat that lasts for years). It aims to see if this approach can help improve symptoms and restore a more normal heart rhythm.
This study is for people with atrial fibrillation who are planning to have a catheter ablation procedure. It will look at how well the heart works after the procedure and how to prevent future events.
Hear when a new Atrial Fibrillation Mitral Valve Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.